These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26970460)

  • 1. Multidrug-resistant TB among previously treated TB cases: A retrospective study in Nagpur, India.
    Munje R; Deshmukh R; Tumane K
    Indian J Tuberc; 2015 Oct; 62(4):207-10. PubMed ID: 26970460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of multidrug resistant tuberculosis in new and treatment-failure patients from the Revised National Tuberculosis Control Programme in an urban metropolis (Mumbai) in Western India.
    D'souza DT; Mistry NF; Vira TS; Dholakia Y; Hoffner S; Pasvol G; Nicol M; Wilkinson RJ
    BMC Public Health; 2009 Jun; 9():211. PubMed ID: 19563647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoniazid mono-resistant tuberculosis: Time to take it seriously.
    Garg K; Saini V; Dhillon R; Agarwal P
    Indian J Tuberc; 2019 Apr; 66(2):247-252. PubMed ID: 31151492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of multi drug resistant tuberculosis in people living with HIV in Western India.
    Saldanha N; Runwal K; Ghanekar C; Gaikwad S; Sane S; Pujari S
    BMC Infect Dis; 2019 May; 19(1):391. PubMed ID: 31068153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unacceptable treatment outcomes and associated factors among India's initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007-2011): Evidence leading to policy enhancement.
    Parmar MM; Sachdeva KS; Dewan PK; Rade K; Nair SA; Pant R; Khaparde SD
    PLoS One; 2018; 13(4):e0193903. PubMed ID: 29641576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug resistant tuberculosis: trends and control.
    Prasad R; Gupta N; Singh M
    Indian J Chest Dis Allied Sci; 2014; 56(4):237-46. PubMed ID: 25962197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of clinical profile of cases of MDR-TB and evaluation of challenges faced in initiation of second line Anti tuberculosis treatment for MDR-TB cases admitted in drug resistance tuberculosis center.
    Mukati S; Julka A; Varudkar HG; Singapurwala M; Agrawat JC; Bhandari D; Jain A
    Indian J Tuberc; 2019 Jul; 66(3):358-363. PubMed ID: 31439180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active case finding of rifampicin sensitive and resistant TB among household contacts of drug resistant TB patients in Andhra Pradesh and Telangana states of India - A systematic screening intervention.
    Chatla C; Jaju J; Achanta S; Samyuktha R; Chakramahanti S; Purad C; Chepuri R; Nair SA; Parmar M
    Indian J Tuberc; 2018 Jul; 65(3):218-224. PubMed ID: 29933863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High rates of multidrug-resistant and rifampicin-resistant tuberculosis among re-treatment cases: where do they come from?
    Ragonnet R; Trauer JM; Denholm JT; Marais BJ; McBryde ES
    BMC Infect Dis; 2017 Jan; 17(1):36. PubMed ID: 28061832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Operational challenges in diagnosing multi-drug resistant TB and initiating treatment in Andhra Pradesh, India.
    Chadha SS; Sharath BN; Reddy K; Jaju J; Vishnu PH; Rao S; Parmar M; Satyanarayana S; Sachdeva KS; Wilson N; Harries AD
    PLoS One; 2011; 6(11):e26659. PubMed ID: 22073182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and factors associated with multidrug-resistant tuberculosis in South India.
    Shivekar SS; Kaliaperumal V; Brammacharry U; Sakkaravarthy A; Raj CKV; Alagappan C; Muthaiah M
    Sci Rep; 2020 Oct; 10(1):17552. PubMed ID: 33067551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis.
    Eshetie S; Gizachew M; Dagnew M; Kumera G; Woldie H; Ambaw F; Tessema B; Moges F
    BMC Infect Dis; 2017 Mar; 17(1):219. PubMed ID: 28320336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profile of drug-resistant-conferring mutations among new and previously treated pulmonary tuberculosis cases from Aligarh region of Northern India.
    Ahmed S; Shukla I; Fatima N; Varshney SK; Shameem M; Tayyaba U
    Int J Mycobacteriol; 2018; 7(4):315-327. PubMed ID: 30531028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High rates of ofloxacin resistance in Mycobacterium tuberculosis among both new and previously treated patients in Tamil Nadu, South India.
    Selvakumar N; Kumar V; Balaji S; Prabuseenivasan S; Radhakrishnan R; Sekar G; Chandrasekaran V; Kannan T; Thomas A; Arunagiri S; Dewan P; Swaminathan S
    PLoS One; 2015; 10(3):e0117421. PubMed ID: 25738956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends of anti-tuberculosis drug resistance pattern in new cases and previously treated cases of extrapulmonary tuberculosis cases in referral hospitals in northern India.
    Maurya AK; Kant S; Nag VL; Kushwaha RA; Dhole TN
    J Postgrad Med; 2012; 58(3):185-9. PubMed ID: 23023350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern and trends of drug sensitivity in MDR-TB cases in Delhi (2009-2014): A record based study.
    Sharma N; Singla N; Khanna A; Basu S; Chopra KK; Chandra S; Kohli C
    Indian J Tuberc; 2019 Apr; 66(2):222-226. PubMed ID: 31151488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of multidrug-resistant tuberculosis in Thailand.
    Maranetra KN
    Chemotherapy; 1996; 42 Suppl 3():10-5; discussion 30-3. PubMed ID: 8980862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High pre-diagnosis attrition among patients with presumptive MDR-TB: an operational research from Bhopal district, India.
    Shewade HD; Kokane AM; Singh AR; Verma M; Parmar M; Chauhan A; Chahar SS; Tiwari M; Khan SN; Gupta V; Tripathy JP; Nagar M; Singh SK; Mehra PK; Kumar AM
    BMC Health Serv Res; 2017 Apr; 17(1):249. PubMed ID: 28376789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of different subgroups of smear-positive retreatment patients under RNTCP in rural West Bengal, India.
    Mukherjee A; Sarkar A; Saha I; Biswas B; Bhattacharyya PS
    Rural Remote Health; 2009; 9(1):926. PubMed ID: 19260766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological and behavioural correlates of drug-resistant tuberculosis in a Tertiary Care Centre, Delhi, India.
    Dzeyie KA; Basu S; Dikid T; Bhatnagar AK; Chauhan LS; Narain JP
    Indian J Tuberc; 2019 Jul; 66(3):331-336. PubMed ID: 31439176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.